Rights and permissions
About this article
Cite this article
Ticarcillin/clavulanic acid switch programme cost saving. Pharmacoecon. Outcomes News 42, 9 (1995). https://doi.org/10.1007/BF03309915
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03309915